GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medius Holdings Co Ltd (TSE:3154) » Definitions » EBIT

Medius Holdings Co (TSE:3154) EBIT : 円1,701 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Medius Holdings Co EBIT?

Medius Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was 円1,099 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was 円1,701 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medius Holdings Co's annualized ROC % for the quarter that ended in Mar. 2024 was 4.82%. Medius Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 19.43%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medius Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.72%.


Medius Holdings Co EBIT Historical Data

The historical data trend for Medius Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medius Holdings Co EBIT Chart

Medius Holdings Co Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 481.90 1,378.87 3,231.92 2,635.86 2,603.74

Medius Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,456.61 -338.63 216.86 723.64 1,098.91

Competitive Comparison of Medius Holdings Co's EBIT

For the Medical Instruments & Supplies subindustry, Medius Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medius Holdings Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medius Holdings Co's EV-to-EBIT falls into.



Medius Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,701 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medius Holdings Co  (TSE:3154) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medius Holdings Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=3889.044 * ( 1 - 40.34% )/( (47138.269 + 49110.885)/ 2 )
=2320.2036504/48124.577
=4.82 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=112609.855 - 61571.608 - ( 14028.736 - max(0, 86800.822 - 90700.8+14028.736))
=47138.269

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=115179.027 - 62534.366 - ( 14992.594 - max(0, 87583.568 - 91117.344+14992.594))
=49110.885

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medius Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4395.628/( ( (11153.914 + max(12227.884, 0)) + (11779.032 + max(10077.936, 0)) )/ 2 )
=4395.628/( ( 23381.798 + 21856.968 )/ 2 )
=4395.628/22619.383
=19.43 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(60129.205 + 12912.445 + 3630.414) - (61571.608 + 0 + 2872.572)
=12227.884

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(60371.387 + 12357.973 + 3395.39) - (62534.366 + 0 + 3512.448)
=10077.936

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medius Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=1700.773/29734.043
=5.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medius Holdings Co EBIT Related Terms

Thank you for viewing the detailed overview of Medius Holdings Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medius Holdings Co (TSE:3154) Business Description

Traded in Other Exchanges
N/A
Address
1 - 1 Kyobashi 1 - Chome, Chuo-ku, Tokyo, JPN, 104-0031
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds.

Medius Holdings Co (TSE:3154) Headlines

No Headlines